explore -WSS

explore

author：explore 2025-10-02 21:00:20 - browse：84

A display of TVs against an orange background. -- health policy coverage from STAT — Adobe

WASHINGTON — Government regulators may soon decide whether to crack down on distracting visuals in television drug commercials or require subtitles about side effects, a regulation that’s been 13 years in the making.

White House budget experts are reviewing changes to the regulation of broadcast drug advertisements that the Food and Drug Administration proposed in 2010, according to the Office of Management and Budget website. That proposal aimed to make commercials present drug risks in a manner that consumers notice and understand.

Drug ads have long been controversial. Aside from New Zealand, the United States is the only country that allows drug makers to advertise to consumers. Critics of drug ads say they pose consumer safety concerns by bombarding the public with promotions that distract viewers from potential side effects. Drug companies say commercials spark conversations between patients and doctors that promote clinically beneficial prescribing.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Listen: A conversation with researcher Kevin Esvelt on biosecurity

WSS

FDA drug safety: Singulair case shows systemic surveillance flaws

Questions and answers about ramping up H5N1 bird flu vaccine

Do digital therapeutics have a future in medicine?

H5N1 bird flu outbreak: Second human case reported, in Michigan

Quicker fix for pulse oximeters urged during FDA public meeting

Apple Vision Pro: A first look at health apps on the new VR headset

Wikipedia

explore

entertainment

The cancer drug shortage isn’t new — and neither are the solutions

UnitedHealth argues against case alleging wrongful AI care denials

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

H5N1 virus can be tracked in retail milk, scientists say

Heart attack and stroke risk calculators need revising

Time to name cancers by genetics, not organ of origin, expert says

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Study finds gene variants tied to breast cancer risk in Black women

23andMe had bad news about my health. I wish a person had delivered it

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

leisure time

Some dementia cases could be undiagnosed liver disease

As a primary care physician, here's how I hope to partner with AI

General Catalyst, Summa Health deal will turn on physician buy

As a primary care physician, here's how I hope to partner with AI

Cybersecurity threat forces Lurie Children's to take systems offline

At flashy new research hub, AstraZeneca lays out ambitious growth goals

Wikipedia

Wikipedia

focus

focus